ACTIVATION OF COMPLEMENT BY HUMAN HEMOGLOBIN AND BY MIXTURES OF HEMOGLOBIN AND BACTERIAL-ENDOTOXIN

被引:19
作者
KACA, W
ROTH, R
机构
[1] UNIV CALIF SAN FRANCISCO, SCH MED, DEPT LAB MED, SAN FRANCISCO, CA 94121 USA
[2] VET ADM MED CTR, SAN FRANCISCO, CA 94121 USA
[3] UNIV LODZ, INST MICROBIOL & IMMUNOL, LODZ, POLAND
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 1995年 / 1245卷 / 01期
关键词
COMPLEMENT ACTIVATION; CELL-FREE HEMOGLOBIN; CROSS-LINKED HEMOGLOBIN; BACTERIAL LIPOPOLYSACCHARIDE;
D O I
10.1016/0304-4165(95)00077-O
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purified human hemoglobin is being developed as an alternative to transfusions of homologous erythrocytes. However, toxicity associated with infusion of hemoglobin has limited the development of this resuscitation fluid. Some observed toxicities, including activation of the complement cascade, have been associated with contamination of hemoglobin solutions by bacterial endotoxin. Recent studies have demonstrated complex formation between hemoglobin and endotoxin, and have documented a resultant increase in the ability of endotoxin to activate coagulation, stimulate tissue factor production by human peripheral blood mononuclear cells, and stimulate tissue factor activity and protein synthesis in cultured human endothelial cells. The process of hemoglobin enhancement of endotoxin toxicity suggests a possible mechanism by which the consequences of endotoxin contamination of hemoglobin solutions, including complement activation, could be magnified. Therefore, we studied the potential of hemoglobin to either fix complement directly, or modify the ability of endotoxin to fix complement. Human crosslinked and native hemoglobins, at concentrations between 0.2 mg/ml and 3 mg/ml, were shown to fix complement, Complement fixation by hemoglobin was identical in normal human serum or in factor B-depleted serum, suggesting that fixation occurred via the classical pathway of complement activation. Complement fixation then was examined with a battery of smooth and rough endotoxins tested in the absence and presence of hemoglobin, Addition of hemoglobin to a solution of a rough Salmonella endotoxin partial structure, from which a single fatty acid had been hydrolyzed from the lipid A portion of the macromolecule, resulted in decreased efficiency of complement fixation. However, addition of hemoglobin had little or no effect on the intrinsic complement fixing abilities of eight other smooth endotoxins, rough endotoxins, or endotoxin partial structures. Our results demonstrated the ability of hemoglobin to fix complement at hemoglobin concentrations which would be achieved during infusion for resuscitation, but failed to demonstrate a reproducible effect of hemoglobin on the activation of complement by endotoxin.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 49 条
[1]  
ALBERTI S, 1993, INFECT IMMUN, V61, P852
[2]  
BOLIN R, 1983, ADV BLOOD SUBSTITUTE, P117
[3]  
BORNSIDE GH, 1970, SURGERY, V68, P350
[4]   DIFFERENTIAL DETERMINATION OF THE 3-DEOXY-D-MANNOOCTULOSONIC ACID RESIDUES IN LIPOPOLYSACCHARIDES OF SALMONELLA-MINNESOTA ROUGH MUTANTS [J].
BRADE, H ;
GALANOS, C ;
LUDERITZ, O .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 131 (01) :195-200
[5]   MICROANGIOPATHIC HAEMOLYTIC ANAEMIA - OCCURRENCE OF HAEMOLYSIS IN EXPERIMENTALLY PRODUCED VASCULAR DISEASE [J].
BRAIN, MC ;
HOURIHANE, DO .
BRITISH JOURNAL OF HAEMATOLOGY, 1967, 13 (01) :135-+
[6]   THE EFFECTS OF HEMOGLOBIN SOLUTIONS ON RENAL FUNCTIONS IN MAN [J].
BRANDT, JL ;
FRANK, NR ;
LICHTMAN, HC .
BLOOD, 1951, 6 (11) :1152-1158
[7]   ASSESSMENT OF BLOOD SUBSTITUTES .2. IN-VITRO COMPLEMENT ACTIVATION OF HUMAN PLASMA AND BLOOD FOR SAFETY STUDIES IN RESEARCH, DEVELOPMENT, INDUSTRIAL-PRODUCTION AND PRECLINICAL ANALYSIS [J].
CHANG, TMS ;
LISTER, CW .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (02) :171-180
[8]   A SCREENING-TEST FOR MODIFIED HEMOGLOBIN BLOOD SUBSTITUTES BEFORE CLINICAL USE - BASED ON C3A COMPLEMENT ACTIVATION IN HUMAN PLASMA [J].
CHANG, TMS ;
LISTER, C .
BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1990, 18 (05) :693-701
[9]   PILOT SCALE PRODUCTION OF PYROGEN-FREE HUMAN HEMOGLOBIN FOR RESEARCH [J].
CHAPMAN, KW ;
SNELL, SM ;
JESSE, RG ;
MORANO, JK ;
EVERSE, J ;
WINSLOW, RM .
BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4) :415-421
[10]   PREPARATION OF HUMAN HEMOGLOBIN-AO FOR POSSIBLE USE AS A BLOOD SUBSTITUTE [J].
CHRISTENSEN, SM ;
MEDINA, F ;
WINSLOW, RW ;
SNELL, SM ;
ZEGNA, A ;
MARINI, MA .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1988, 17 (02) :143-154